Log In
Print
BCIQ
Print
Print this Print this
 

MRX-6, MRX6

  Manage Alerts
Collapse Summary General Information
Company Celsus Therapeutics plc
DescriptionTopical multifunctional anti-inflammatory compound that inhibits phospholipase A2 (PLA2)
Molecular Target Phospholipase A2 (PLA2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat allergic contact dermatitis; Treat atopic dermatitis (eczema); Treat mild to moderate atopic dermatitis in pediatric patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today